For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal ...
The presence of anti-CCP in a person’s blood may indicate they have rheumatoid arthritis (RA). When the immune system produces anti-CCP, it triggers a series of reactions that damage tissues in the ...
Diagnosis of rheumatoid arthritis (RA) is largely clinical, based on key historic and physical findings and serial observation of symptoms, signs and response to therapies. Observation during the ...
For the 5 tests, the cumulative probabilities of very abnormal laboratory results varied from 0.2% for leukocyte count to 6.6% for eGFR at 2 years and from 0.3 to 11%, respectively, at 5 years.